Sunam Mander
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Intracellular redistribution of cell-penetrating peptide p28: A mechanism for enhanced anti-cancer activity.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 20, 2024
Improvement of DCIS resection using intraoperative imaging with ICG-p28.
Journal: Scientific reports
Published: May 17, 2023
The brain-penetrant cell-cycle inhibitor p28 sensitizes brain metastases to DNA-damaging agents.
Journal: Neuro-oncology advances
Published: May 17, 2023
Tumor-targeting cell-penetrating peptide, p28, for glioblastoma imaging and therapy.
Journal: Frontiers in oncology
Published: May 09, 2022
SP-8356, a (1S)-(-)-Verbenone Derivative, Inhibits the Growth and Motility of Liver Cancer Cells by Regulating NF-κB and ERK Signaling.
Journal: Biomolecules & therapeutics
Published: November 05, 2020
SP-8356, a (1S)-(-)-verbenone derivative, exerts in vitro and in vivo anti-breast cancer effects by inhibiting NF-κB signaling.
Journal: Scientific reports
Published: October 24, 2018
Nafamostat mesilate negatively regulates the metastasis of triple-negative breast cancer cells.
Journal: Archives of pharmacal research
Published: July 07, 2017
Characterization of Functional Domains in NME1L Regulation of NF-κB Signaling.
Journal: Molecules and cells
Published: November 25, 2015
NME1L Negatively Regulates IGF1-Dependent Proliferation of Breast Cancer Cells.
Journal: Journal of cellular biochemistry
Published: May 31, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026